Key Takeaways
- Human studies consistently show that NMN can increase NAD+ levels, a coenzyme essential for cellular energy production and cellular maintenance.
- Published clinical trials have reported favourable safety and tolerability outcomes across a range of doses.
- While researchers continue to expand long-term investigations, NMN remains one of the most actively studied compounds in the science of healthy ageing.
Few areas of longevity science have attracted as much attention in recent years as NMN. Researchers around the world are investigating how this naturally occurring molecule may support NAD+, a coenzyme involved in cellular energy production, DNA repair and many of the biological processes associated with healthy ageing.
One fascinating fact is that NAD+ is found in every living cell and is required for hundreds of enzymatic reactions every day. Because NAD+ levels naturally decline with age, scientists have become increasingly interested in ways to support its production and availability throughout life. The findings so far have been encouraging, particularly regarding safety, NAD+ production, and cellular health.
Why NAD+ Has Become a Major Focus in Healthy Ageing Research
To understand why NMN has become such an important area of research, it helps to first understand the role of NAD+. NAD+ is a coenzyme that helps cells convert nutrients into usable energy. It also supports important cellular processes, including mitochondrial function, DNA repair and the activity of sirtuins, a family of proteins associated with cellular maintenance and resilience. As NAD+ levels naturally decline over time, researchers have explored whether supporting NAD+ production may help maintain healthy cellular function (R).
This is where NMN enters the picture. NMN acts as a direct precursor to NAD+, meaning the body can use it as a building block to produce more NAD+. Human clinical trials have repeatedly demonstrated that NMN can effectively increase NAD+ levels in the bloodstream, confirming that it reaches its intended biological target (R).
Human Research Continues to Deliver Encouraging Safety Findings
One of the most reassuring aspects of NMN research is the consistency of the safety data. Across multiple human clinical trials, researchers have reported favourable tolerability, with no serious adverse events associated with NMN supplementation. Studies have investigated doses ranging from 250 mg to 1,250 mg daily and have generally found NMN to be well tolerated in healthy adults (R).
A systematic review of randomised controlled trials reached a similar conclusion, reporting that NMN administration was safe and well-tolerated, with no serious adverse effects observed across the studies (R).
This growing body of safety data is one reason NMN has become one of the most closely watched molecules in longevity science. While researchers continue to investigate longer durations of use, the consistency of findings across human studies has helped build confidence in its safety profile (R).
Consistently Increasing NAD+ Levels Is a Significant Finding
Among the findings from human research, one result appears repeatedly: NMN increases NAD+ levels. Clinical studies have demonstrated significant increases in blood NAD+ concentrations following NMN supplementation. Why does this matter? Because NAD+ sits at the centre of cellular energy metabolism.
Every cell relies on NAD+ to help produce energy, respond to stress and support cellular repair mechanisms. Researchers often describe NAD+ as one of the body’s most important molecules because of its involvement in so many biological processes (R). The ability of NMN to reliably increase NAD+ levels in humans is one of the strongest pieces of evidence supporting ongoing interest in this area of healthy ageing research (R).
What Are Scientists Learning About Physical Vitality?
As research continues to expand, scientists are also investigating how NAD+ support may influence aspects of physical function. Several human studies have reported encouraging findings relating to physical performance measures. A 2024 systematic review of randomised controlled trials concluded that NMN may positively influence physical performance outcomes while maintaining a strong safety profile (R).
Researchers are particularly interested in this area because skeletal muscle requires substantial amounts of energy. Since NAD+ plays a fundamental role in mitochondrial energy production, scientists continue to explore how supporting healthy NAD+ levels may help maintain physical vitality as we age (R). While research is ongoing, these early findings help explain why NMN continues to attract attention from researchers studying healthy ageing and cellular function.
The Exciting Future of Long-Term NMN Research
One of the most exciting aspects of NMN research is how rapidly the field is evolving. Most human clinical trials have been conducted in the last few years, creating a growing body of evidence on safety, tolerability, and NAD+ production. Researchers around the world are now conducting larger, longer-term studies to deepen our understanding of how supporting NAD+ pathways may contribute to healthy ageing over time (R).
Importantly, every new study continues to build upon a consistent foundation. Human trials repeatedly demonstrate that NMN is biologically active, effectively increases NAD+ levels and has shown favourable safety outcomes across a variety of populations (R). This growing evidence base is helping to establish NMN as one of the most promising areas of investigation in longevity science today.
Interested in learning more about the science of NAD+ and healthy ageing? Read our related article here: NMN: Side Effects and Safety Considerations.
